| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |